Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Erps

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Klinische Padiatrie|May 1, 1988
[Continuous doxorubicin infusions. A pilot study in young patients]U Bode, M Erps, W Köhler
Pediatric Hematology and Oncology|January 1, 1987
42-hour methotrexate infusions as relapse therapy for childhood malignancies: toxicity and efficacy of 109 infusionsU Bode, M Erps, D Schiffer
Klinische Padiatrie|November 1, 1986
[Immunoglobulin administration as infection prevention in oncologic patients]U Bode, M Erps, N Liappis
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Klinische Padiatrie|May 1, 1988
[Continuous doxorubicin infusions. A pilot study in young patients]U Bode, M Erps, W Köhler
Pediatric Hematology and Oncology|January 1, 1987
42-hour methotrexate infusions as relapse therapy for childhood malignancies: toxicity and efficacy of 109 infusionsU Bode, M Erps, D Schiffer
Klinische Padiatrie|November 1, 1986
[Immunoglobulin administration as infection prevention in oncologic patients]U Bode, M Erps, N Liappis
Pageof 1